Navigation Links
Genes discovered that allow gum disease bacterium to invade arteries

Researchers have identified the genes in gum-disease bacteria that allow them to invade and infect human arterial cells, offering one possible explanation for a perceived connection between gum disease and heart disease. Scientists from the University of Florida, Gainesville, present their findings today at the 106th General Meeting of the American Society for Microbiology in Orlando, Florida.

"Aside from lifestyle and genetic factors, there is increasing evidence that bacterial infections may play a role in heart disease. Porphyromas gingivalis, an important bacterium that causes gum disease, is also linked to cardiovascular disease. In this study we have identified and studied four genes of P. gingivalis that allow it to infect and survive inside artery cells," says Paulo Rodrigues, a researcher on the study.

Rodrigues and his colleagues had previously discovered that P. gingivalis had the ability to invade and survive inside human artery cells. In this study they examined the role four different genes play in this ability. They created four strains of the bacterium, each with a different gene mutated to disable it, and tested their ability to invade and survived in artery cells compared to a fully functioning strain of P. gingivalis.

"Our study showed that all four mutated strains were defective in invasion of the artery cells and that their ability to survive inside of the cells was diminished. These results show that these four genes play a role in the invasion and survival of P. gingivalis inside artery cells," says Rodrigues. "The knowledge of how this pathogenic bacterium interacts with artery cells is important and may lead to the development of therapeutics and diagnostic tools for the detection and possibly prevention of heart diseases caused by this association."


'"/>

Source:American Society for Microbiology


Page: 1

Related biology news :

1. Genes In The Interferon System Important In Systemic Lupus Erythematosus
2. Protein Packages Found To Activate Genes; May Be What Regulates Development And Disease
3. VCU Researchers Identify Networks Of Genes Responding To Alcohol In The Brain
4. Genpathway and Baylor College of Medicine Identify New Genes in Breast Cancer
5. Where Bacteria Get Their Genes
6. Genes linked to treatment resistance in children with leukemia
7. Noise And Delays Explain Why Some Genes Oscillate In Activity
8. Genes involved in biofilms
9. Genes involved in cell growth and cell division identified
10. Genes affecting blood pressure change as children become adults
11. Genes and genius: Researchers confirm association between gene and intelligence
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2016)... GOTHENBURG, Sweden , April 28, 2016 ... 1,491.2 M (139.9), up 966% compared with the first quarter of ... Operating profit totaled SEK 589.1 M (loss: 18.8) and the operating ... SEK 7.12 (loss: 0.32) Cash flow from operations was ... , The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
(Date:4/15/2016)... 2016 Research and Markets has ... Market 2016-2020,"  report to their offering.  , ... ,The global gait biometrics market is expected to ... period 2016-2020. Gait analysis generates multiple ... used to compute factors that are not or ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June 23, 2016   EpiBiome , ... secured $1 million in debt financing from Silicon Valley ... up automation and to advance its drug development efforts, ... new facility. "SVB has been an incredible ... the services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... OTTAWA, ON (PRWEB) , ... June 23, 2016 , ... ... former DNA Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA ... joining the STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... 23, 2016 Andrew ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... journal from touchONCOLOGY, Andrew D Zelenetz , ... cancer care is placing an increasing burden on ... biologic therapies. With the patents on many biologics ...
Breaking Biology Technology: